Nobuaki Ito Selected Research

Hyperostosis-hyperphosphatemia syndrome

1/2021	Congenital Hyperphosphatemic Conditions Caused by the Deficient Activity of FGF23.
2/2007	Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobuaki Ito Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 05/2016
10	Hypophosphatemia 01/2022 - 09/2007
8	Osteomalacia 01/2022 - 10/2007
7	Pain (Aches) 06/2022 - 05/2016
6	Oncogenic osteomalacia 01/2022 - 01/2017
5	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 01/2022 - 10/2009
5	Hyperphosphatemia 01/2021 - 10/2005
5	Rickets (Rachitis) 01/2020 - 10/2007
3	Hypophosphatemic Rickets 01/2022 - 10/2009
3	Hypocalcemia 08/2019 - 01/2009
2	Hypophosphatasia 06/2022 - 01/2021
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 06/2022 - 02/2007
2	Nephrocalcinosis 04/2022 - 01/2018
2	Hyperparathyroidism 04/2022 - 09/2007
2	Hypoparathyroidism 01/2021 - 01/2009
2	Hyperostosis-hyperphosphatemia syndrome 01/2021 - 02/2007
2	Cough 06/2002 - 01/2002
1	Disease Progression 01/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Osteoporosis 01/2022
1	Margins of Excision 09/2021
1	Pseudohypoparathyroidism 01/2021
1	Fatigue 01/2021
1	Familial Hyperphosphatemic Tumoral Calcinosis 01/2021
1	Neurofibroma 12/2019
1	Headache (Headaches) 12/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2019
1	Primary Hyperparathyroidism 08/2019
1	Myalgia 08/2019
1	Dehydration (Water Stress) 08/2019
1	Hypercalcemia (Milk Alkali Syndrome) 08/2019
1	Nausea 08/2019
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 06/2019
1	Osteoarthritis 01/2018
1	Secondary Hyperparathyroidism 06/2017
1	Type 2A Vitamin D-Dependent Rickets 06/2017
1	Alopecia (Baldness) 06/2017
1	Leukemia 12/2016
1	Bone Diseases (Bone Disease) 05/2016
1	Spontaneous Fractures (Pathological Fracture) 05/2016
1	Neoplasm Metastasis (Metastasis) 05/2016
1	Spinal Cord Compression 05/2016
1	Mental Disorders (Mental Disorder) 09/2014
1	Central Nervous System Diseases (CNS Diseases) 09/2014
1	Anorexia Nervosa 01/2010
1	Liver Diseases (Liver Disease) 01/2010
1	Hypoglycemia (Reactive Hypoglycemia) 01/2010
1	Coma (Comas) 01/2010
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 10/2009
1	Tetany (Spasmophilia) 08/2007
1	Acromegaly 06/2007

Drug/Important Bio-Agent (IBA)

13	Fibroblast Growth Factor-23IBA 01/2022 - 10/2005
13	Phosphates (Orthophosphate)IBA 01/2022 - 10/2005
7	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022 - 02/2007
6	burosumabIBA 01/2021 - 01/2018
5	1,25-dihydroxyvitamin DIBA 12/2019 - 02/2007
4	CalciumIBA 08/2019 - 08/2007
3	Pharmaceutical PreparationsIBA 01/2021 - 09/2014
3	Parathyroid Hormone (Parathormone)IBA 01/2021 - 01/2009
2	asfotase alfaIBA 06/2022 - 01/2021
2	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 06/2022 - 01/2021
2	pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate (PMTS)IBA 01/2022 - 01/2019
2	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2021 - 01/2018
2	Monoclonal AntibodiesIBA 09/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 06/2017 - 06/2002
2	Vitamin D FDA LinkGeneric 06/2017 - 10/2014
2	Capsaicin (Zostrix)FDA Link 06/2002 - 01/2002
1	Alkaline PhosphataseIBA 06/2022
1	MineralsIBA 01/2022
1	Hormones (Hormone)IBA 12/2021
1	IronIBA 12/2021
1	Capsules (Microcapsules)IBA 09/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Coloring Agents (Dyes)IBA 12/2019
1	Cinacalcet (Sensipar)FDA Link 08/2019
1	NitrogenIBA 01/2019
1	hydroxide ionIBA 06/2017
1	Codon (Codons)IBA 06/2017
1	Calcitriol Receptors (Calcitriol Receptor)IBA 06/2017
1	von Willebrand FactorIBA 12/2016
1	Zoledronic Acid (Zometa)FDA Link 05/2016
1	Denosumab FDA Link 05/2016
1	LigandsIBA 05/2016
1	Dopamine (Intropin)FDA LinkGeneric 09/2014
1	brexpiprazoleIBA 09/2014
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2014
1	Serotonin (5 Hydroxytryptamine)IBA 09/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2010
1	Saccharated Ferric Oxide (Venofer)FDA Link 10/2009
1	MagnesiumIBA 08/2007

Therapy/Procedure

4	Therapeutics 06/2022 - 08/2007
2	Curettage 01/2019 - 12/2017
1	Parathyroidectomy 04/2022
1	Intravenous Infusions 12/2021
1	Bandages (Bandage) 12/2019
1	Complementary Therapies (Alternative Medicine) 08/2019
1	Radiotherapy 05/2016
1	Parenteral Nutrition 01/2010
1	Intravenous Administration 10/2009
1	Transplantation 09/2007